Target intelligence / Profile preview

MicroRNA 635 (miR-635)

Target
miR-635
Molecular classification
Other (microRNA, non-coding RNA)
01

Overview

MicroRNA 635 (miR-635) is a short non-coding RNA molecule (miRNA) that functions primarily in the post-transcriptional regulation of gene expression, typically by inducing mRNA degradation or translational repression through partial base pairing with target mRNAs[3][5]. It is processed from a stem-loop precursor and incorporated into the RNA-induced silencing complex (RISC), which guides it to its molecular targets[3][5]. miR-635 acts as a tumor suppressor in various cancers, notably inhibiting cell invasion and xenograft tumor growth in non-small cell lung cancer and showing differential expression in normal versus cancerous tissues[1][3]. It also targets transcription factors such as Ying Yang 1 (YY1), thereby influencing cell proliferation, invasion, and other cancer-associated behaviors[1][3]. Diseases associated with MIR635 include ovarian cancer and potentially other malignancies, but as of now, there are no specific drugs known to interact directly with miR-635, nor is it classified as a therapeutic target like a classic receptor, enzyme, or transporter[3].

Other names
hsa-mir-635MIRN635MIR635
02

Biological functions

Post-transcriptional gene regulationRegulation of mRNA stabilityRegulation of mRNA translationCell proliferationCell invasionTumor suppression
03

Disease associations

CancerOvarian cancerNon-small cell lung cancer

Beyond the preview

Go deeper on MicroRNA 635 (miR-635).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 635 (miR-635).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call